Yield10 Bioscience Price Prediction

YTENDelisted Stock  USD 1.90  0.04  2.06%   
As of today the relative strength index (rsi) of Yield10 Bioscience's share price is below 20 . This entails that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

0

 
Oversold
 
Overbought
The successful prediction of Yield10 Bioscience's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Yield10 Bioscience, which may create opportunities for some arbitrage if properly timed.
Using Yield10 Bioscience hype-based prediction, you can estimate the value of Yield10 Bioscience from the perspective of Yield10 Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Yield10 Bioscience to buy its stock at a price that has no basis in reality. In that case, they are not buying Yield10 because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Yield10 Bioscience after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Yield10 Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
1.871.872.09
Details
Naive
Forecast
LowNextHigh
1.821.821.82
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.881.931.98
Details

Yield10 Bioscience After-Hype Price Prediction Density Analysis

As far as predicting the price of Yield10 Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Yield10 Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Yield10 Bioscience, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Yield10 Bioscience Estimiated After-Hype Price Volatility

In the context of predicting Yield10 Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Yield10 Bioscience's historical news coverage. Yield10 Bioscience's after-hype downside and upside margins for the prediction period are 1.90 and 1.90, respectively. We have considered Yield10 Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
1.90
1.90
After-hype Price
1.90
Upside
Yield10 Bioscience is very steady at this time. Analysis and calculation of next after-hype price of Yield10 Bioscience is based on 3 months time horizon.

Yield10 Bioscience Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Yield10 Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Yield10 Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Yield10 Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Any time
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
1.90
1.90
0.00 
0.00  
Notes

Yield10 Bioscience Hype Timeline

Yield10 Bioscience is at this time traded for 1.90. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Yield10 is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Yield10 Bioscience is about 0.0%, with the expected price after the next announcement by competition of 1.90. About 13.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 43.68. Yield10 Bioscience last dividend was issued on the 16th of January 2020. The entity had 1:24 split on the 3rd of May 2024. Given the investment horizon of 90 days the next forecasted press release will be any time.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Yield10 Bioscience Related Hype Analysis

Having access to credible news sources related to Yield10 Bioscience's direct competition is more important than ever and may enhance your ability to predict Yield10 Bioscience's future price movements. Getting to know how Yield10 Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Yield10 Bioscience may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
KPLUYKS AG DRC 0.00 0 per month 2.34 (0.04) 2.94 (3.74) 15.06 
IPIIntrepid Potash 0.00 0 per month 2.07  0.02  4.33 (3.28) 14.45 
CGAChina Green Agriculture 0.00 0 per month 6.37  0.04  10.00 (10.10) 54.67 
BIOXBioceres Crop Solutions 0.00 0 per month 0.00 (0.25) 2.78 (4.17) 13.79 
MBCFItafos Inc 0.00 0 per month 2.04 (0.03) 5.13 (4.80) 17.88 
VNPKFVerde Agritech 0.00 0 per month 4.52  0.02  13.33 (8.51) 35.22 
YARIYYara International ASA 0.00 0 per month 0.00 (0.09) 2.65 (2.24) 10.22 
BHILBenson Hill, Common 0.00 0 per month 0.00 (0.22) 3.49 (7.90) 26.83 
AVDAmerican Vanguard 0.00 0 per month 2.40 (0.01) 4.06 (3.59) 15.23 
LVROLavoro Limited Class 0.00 0 per month 3.82 (0.01) 9.00 (5.91) 24.92 
ICLICL Israel Chemicals 0.00 0 per month 2.14 (0.04) 4.20 (3.06) 9.87 
FMCFMC Corporation 0.00 0 per month 0.00 (0.1) 3.12 (3.42) 16.03 
CFCF Industries Holdings 0.00 0 per month 1.77 (0) 2.17 (2.22) 6.82 
MOSThe Mosaic 0.00 0 per month 0.00 (0.11) 4.43 (3.92) 13.10 
NTRNutrien 0.00 0 per month 0.00 (0.12) 2.31 (2.10) 8.77 
SMGScotts Miracle Gro 0.00 0 per month 3.91  0.01  4.22 (3.44) 25.99 
CTVACorteva 0.00 0 per month 1.42  0.02  2.88 (2.38) 7.90 

Yield10 Bioscience Additional Predictive Modules

Most predictive techniques to examine Yield10 price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Yield10 using various technical indicators. When you analyze Yield10 charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Yield10 Bioscience Predictive Indicators

The successful prediction of Yield10 Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Yield10 Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Yield10 Bioscience based on analysis of Yield10 Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Yield10 Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Yield10 Bioscience's related companies.

Story Coverage note for Yield10 Bioscience

The number of cover stories for Yield10 Bioscience depends on current market conditions and Yield10 Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Yield10 Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Yield10 Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Yield10 Bioscience Short Properties

Yield10 Bioscience's future price predictability will typically decrease when Yield10 Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Yield10 Bioscience often depends not only on the future outlook of the potential Yield10 Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Yield10 Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding331.1 K
Cash And Short Term Investments1.1 M
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Yield10 Stock

If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine